bicalutamide and Minimal Disease, Residual

bicalutamide has been researched along with Minimal Disease, Residual in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlgren, G; Angelsen, A; Bergh, A; Haugen, OA; Solberg, A; Tasdemir, I; Viset, T; Widmark, A	1
Feek, U; Helpap, B; Kaulfuss, U; Köllermann, J; Köllermann, MW; Müller, H; Oehler, U	1

Trials

1 trial(s) available for bicalutamide and Minimal Disease, Residual

Article	Year
Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial. International journal of radiation oncology, biology, physics, 2011, May-01, Volume: 80, Issue:1 Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality Therapy; Disease Progression; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Nitriles; Odds Ratio; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds	2011

Article

Year

Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.

International journal of radiation oncology, biology, physics, 2011, May-01, Volume: 80, Issue:1

Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality Therapy; Disease Progression; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Nitriles; Odds Ratio; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds

2011

Other Studies

1 other study(ies) available for bicalutamide and Minimal Disease, Residual

Article	Year
Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. European urology, 2000, Volume: 38, Issue:6 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Humans; Leuprolide; Male; Neoplasm, Residual; Nitriles; Prostate; Prostatectomy; Prostatic Neoplasms; Time Factors; Tosyl Compounds	2000